Tag: Resistant bacteria

First approved by the U.S. Food and Drug Administration (FDA) in 1999, the trade name for quinupristin is Synercid, a potent intravenous antibiotic. It is notably used for serious or life-threatening infections caused by bacteria that have developed resistance to other medications.

In 2000, linezolid became the first new class of antibiotic in nearly two decades to pass clinical trials, signaling the arrival of oxazolidinones. These synthetic antibiotics are primarily used to treat serious infections caused by multidrug-resistant Gram-positive bacteria, and prominent examples of oxazolidinones include linezolid and tedizolid.

Amikacin is a semi-synthetic aminoglycoside antibiotic developed to combat bacterial resistance, specifically designed to evade the enzymatic modifications that render earlier antibiotics ineffective. But **what does amikacin do** to achieve this and treat serious infections like sepsis and pneumonia?